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 There has been a rise in the number of women entering pregnancy with preexisting  
type 1 and type 2 diabetes due to changing demographics of the obstetric population, including 
advanced maternal age and obesity. Uncontrolled diabetes during pregnancy is directly 
correlated with adverse perinatal outcomes. Educational approaches need to be taken to 
decrease the advancement of an intergenerational cycle of diabetes fueling the current global 
epidemic. This retrospective chart review aimed to evaluate the relationships between 
completion of education (i.e., diabetes or nutrition) and outcomes measures (i.e., glycemic 
control and birth outcomes) in mothers with preexisting diabetes at an urban Alaska health 
system for the purpose of quality improvement in clinical practice.  
Education provided by a registered dietitian nutritionist and/or certified diabetes educator 
in accordance with the American Diabetes Association Management of Diabetes in 
Pregnancy: Standards of Medical Care in Diabetes – 2020 improves clinical outcomes, 
behaviors, and quality of life. In this study, data from 78 charts were reviewed including BMI, 
HbA1c preconceptionally and during each trimester, pregnancy complications (i.e., 
preeclampsia), birth outcomes (i.e., gestational age, birth weight, cesarean delivery, shoulder 
dystocia, malpresentation, premature rupture of membrane, postpartum hemorrhaging, and fetal 
loss), demographics (i.e., age, employment status, ethnicity), and completion of diabetes 
education or nutrition education. The insufficient availability of outcome measures documented 
in medical charts and low numbers of medical record sharing among facilities limited the ability 
to evaluate the impact of education on glycemic control and subsequent birth outcomes in this 
study.  
The systematic evaluation of outcomes is the backbone to demonstrating the efficacy of 
registered dietitian nutritionists and certified diabetes educators in helping women achieve 
glycemic self-management outcomes. In terms of quality improvement, more documentation is 
needed. Medical data needs to reflect overall care provided in order to gauge the effect of 
iv 
education on glycemic control and birth outcomes. To decrease barriers of reviewing a chart, 
the extraction of chart data should be accomplished solely by the principal investigator. 
Recommendations for future outcomes studies should include collecting data on a continuum of 
clearly defined blood glucose levels during pregnancy to reflect the effect diabetes and nutrition 
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Acceptable blood glucose level during pregnancy: According to the American Diabetes 
Association Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes – 
2020 
• Benchmark: HbA1c < 6.5% 
o Pre-prandial blood glucose 60 to 99 mg/dL 
o Fasting blood glucose < 95 mg/dL and either 
o One-hour postprandial < 140 mg/dL or 
o Two-hour postprandial < 120 mg/dL1 
Unacceptable blood glucose level during pregnancy: According to the American Diabetes 
Association Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes – 
2020 
• HbA1c > 6.5% 
o Pre-prandial blood glucose > 99 mg/dL 
o Fasting blood glucose > 95 mg/dL and either 
o One-hour postprandial > 140 mg/dL or 
o Two-hour postprandial > 120 mg/dL1 
Diabetes education: The process of facilitating knowledge, skills, and ability necessary for 
diabetes self-care to improve clinical outcomes, health status, and quality of life with the 
guidance of a certified diabetes educator (CDE), registered nurse, pharmacist, or other trained 
health professional.2,3 
Certified diabetes educator: A health professional (i.e., registered dietitian nutritionist, registered 
nurse, or medical doctor) who has completed a minimum number of hours in clinical diabetes 
practice, passed the Certification Examination for Diabetes Educators, and has responsibilities 
that include the direct provision of diabetes education.2
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Diabetes-self management education: American Diabetes Association recommended education 
with core content including diabetes disease process treatment options; incorporating nutritional 
management and physical activity into lifestyle; using medications safely for maximum 
therapeutic effectiveness; monitoring blood glucose and other parameters and interpreting and 
using the results for self-management decision making; preventing, detecting, and treating 
acute and chronic complications; developing personal strategies to address psychosocial issues 
and concerns; and developing personal strategies to promote health and behavior change.4 
Nutrition education: Diagnostic, therapy, and counseling services administered by a registered 
dietitian nutritionist (RDN) for the purpose of establishing diabetes management to promote and 
support healthful eating patterns, address individual nutrition needs, provide nonjudgmental 
messages about food choices and provide the individual with practical tools for developing 
healthy eating patterns.5 
Medical nutrition therapy: Treatment of a disease or condition through the modification of 
nutrient or whole-food intake. An evidence-based application of nutrition care process provided 
by a registered dietitian nutritionist. Components of medical nutrition therapy include 
assessment, nutrition diagnosis, interventions (e.g., education and counseling), and monitoring 
with ongoing follow-up to support long-term lifestyle changes, evaluate outcomes, and modify 
interventions as needed.6 
Preexisting/pregestational diabetes: A diagnosis of type 1 diabetes or type 2 diabetes prior to 
pregnancy, excluding gestational diabetes. 
Macrosomia: Refers to growth beyond specific threshold regardless of gestational age, a fetus 
larger than 4000 to 4500 grams.7 
Hemoglobin A1c (HbA1c): An integrated measure of glucose, reflecting average glycemia over 
approximately three months. This measure helps determine if glycemic targets have been 
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reached and maintained. HbA1c does not measure glycemic variability or hypoglycemic events.8 
Completion of education: Attended at least one diabetes education or nutrition education 
appointment during pregnancy provided by a registered dietitian nutritionist or certified diabetes 
educator. 
Gestational hypertension:  
• Systolic blood pressure > 140 mm Hg  
• Diastolic blood pressure > 90 mm Hg or both (on two occasions at least four hours apart) 
• After 20 weeks of gestation in a woman with a previously normal blood pressure 
• Absence of proteinuria9 
Mild preeclampsia 
• Systolic blood pressure > 140 mm Hg  
• Diastolic blood pressure > 90 mm Hg or both (on two occasions at least four hours apart) 
• After 20 weeks of gestation in a woman with a previously normal blood pressure 
• > 300 mg/dL of protein in a 24-hour urine collection9 
Severe preeclampsia:  
• Systolic blood pressure > 160 mm Hg  
• Diastolic blood pressure > 110 mm Hg or both (on two occasions at least four hours 
apart) 
• After 20 weeks of gestation in a woman with a previously normal blood pressure 
• > 500 mg/dL of protein in a 24-hour urine collection9 
Eclampsia: The convulsive manifestation of the hypertensive disorders of pregnancy. New-
onset tonic-clonic, focal, or multifocal seizures in the absence of other causative conditions.9
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Chapter 1: Introduction 
 There has been a rise in the number of women entering pregnancy with preexisting  
type 1 and type 2 diabetes due to changing demographics of the obstetric population, including 
advanced maternal age and obesity.10 “If one-fifth of the 30 million type 2 sufferers in the U.S. 
used dietary changes to reduce HbA1c levels by 1 percent, they would not only reverse the 
course of their diabetes, but the healthcare system would also save at least $10 billion annually 
and outcomes would improve measurably.”11 p.1 Preexisting diabetes during pregnancy is 
correlated with adverse perinatal outcomes such as macrosomia and subsequent cesarean 
delivery, congenital malformation, preterm birth, stillbirth, neonatal mortality, preeclampsia, and 
exacerbated maternal microvascular disease.10 Individualized educational approaches need to 
be utilized to promote glycemic control for women with preexisting diabetes and decrease the 
advancement of an intergenerational cycle of diabetes fueling the current global epidemic. 
Approaches to diabetes self-management should focus on modifying population-specific lifestyle 
behaviors which are reinforced by obtaining education and skills.12 Problematic lifestyle 
behaviors of pregnant women with preexisting diabetes may include poor diet, decreased 
physical activity, and pharmacotherapy noncompliance. These behaviors need to be adapted to 
manage glycemic targets and increased complexity of insulin management. The education and 
skills taught should support the needs of the obstetric population affected by preexisting 
diabetes and recognize the metabolic changes that foster fetal development. Effective diabetes 
and nutrition education have been shown to improve clinical outcomes (i.e., anthropometrics, 
HbA1c, blood glucose, serum lipids, blood pressure) that exacerbate adverse perinatal 
outcomes, behaviors, quality of life, and result in cost savings.13 Barriers to preconception 
education need to be identified and women need to have equal access to prenatal care.  
Currently, there is no consensus of the structure of a multidisciplinary team care for 
pregnancy and diabetes. Prenatal care should consist of nutrition and diabetes education to 
help women achieve optimal glycemic control. Education helps reduce risks by glycemic goal 
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setting, lifestyle management, and medical nutrition therapy.14 Outcome measures (i.e., HbA1c, 
blood glucose levels, gestational age, birth weight, pregnancy complications) of education must 
be tracked regularly. Documented outcome measures support the efficacy of registered dietitian 
nutritionists (RDN) and certified diabetes educator (CDE), thus supporting chart review as one 
methodology for outcomes research.4 The use of a retrospective quality improvement chart 
review also affords time-sensitive and cost-effective dissemination of outcomes to 
stakeholders.13 By conducting a retrospective chart review focused on outcomes research, one 
can identify education processes and subsequent birth outcomes related to glycemic control 
during pregnancy for the purpose of quality improvement.  
Research purpose:  
The purpose of this project was to evaluate the birth outcomes and glycemic control of pregnant 
women with preexisting diabetes receiving diabetes education or nutrition education by a 
registered dietitian nutritionist (RDN) or certified diabetes educator (CDE) during pregnancy 
compared to women that do not receive education with a goal of promoting quality assurance 
and identifying opportunities for evaluating adherence to the American Diabetes Association 
Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes – 2020. 
Objectives: 
1. Examine relationships between completing diabetes education or nutrition education 
appointments and HbA1c levels amongst pregnant women with preexisting diabetes 
type 1 and type 2 diabetes. 
2. Examine relationships between completing education and birth outcomes (i.e., 
gestational age, birth weight, cesarean delivery, shoulder dystocia, malpresentation, 
premature rupture of membrane, postpartum hemorrhaging, and fetal loss) amongst 
pregnant women with preexisting type 1 and type 2 diabetes. 
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3. Examine relationships between HbA1c during each trimester to demographics (i.e., 
ethnicity and employment status), pregnancy risks (i.e., BMI, age, chronic hypertension, 
multiparity) and outcome variables (i.e., pregnancy complications) 
Research question: 
Is the completion of diabetes education or nutrition education among pregnant women with 
preexisting diabetes at an urban Alaska health system associated with the American Diabetes 
Association Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes – 
2020 recommendations for glycemic control? 
 Subquestion: 



















Chapter 2: Literature Review 
 Search terms used for the literature review included: preexisting diabetes, type 1 
diabetes, type 2 diabetes, pregestational diabetes, pregnancy, birth outcomes (i.e., congenital 
malformations, macrosomia, preterm birth, shoulder dystocia, malpresentation, premature 
rupture of membrane, postpartum hemorrhaging, cesarean delivery), pregnancy complications 
(i.e., preeclampsia), prenatal education, diabetes education, diabetes self-management 
education, nutrition education, and medical nutrition therapy. Selected literature was published 
between 2008 and 2020 and found through PubMed and Google Scholar. 
Pregestational Diabetes and Pregnancy 
During pregnancy, all women enter a diabetogenic state in which postprandial glucose 
levels are elevated and insulin sensitivity is decreased due to the presence of growth factors, 
placenta hormones, and cytokines.15 This diabetogenic state begins during the second trimester 
and insulin resistance peaks during the third trimester. During the second trimester when 
women become more insulin resistant, insulin needs may change on a weekly basis. 
Physiological changes that occur during pregnancy are essential for sufficient nutrition and 
growth of the fetus. Changes include increased hepatic glucose production in the fasting state 
and maternal peripheral insulin resistance, which increases glucose supply and availability to 
the fetus.16  
Women with type 2 diabetes are more likely to achieve euglycemia with treatment, 
compared to women with type 1 diabetes.17 For women with type 1 diabetes, this feat is more 
challenging and needs to be balanced with risks of hypoglycemia.17 Insulin therapies need to be 
safe, individualized, and adapted to women’s needs as they progress through pregnancy. This 
is especially important during delivery as women are increasingly sensitive to insulin and insulin 
needs drop to 50 to 90% of prepregnancy needs.18 For women with preexisting diabetes, these 
changes during pregnancy equate to fluctuating glucose levels and the need for nonjudgmental 
and positively focused care provided by qualified health care professionals.1  
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Maternal glucose metabolism adapts during pregnancy in order to provide a continuous 
supply of glucose to the fetus. These metabolic changes coupled with preexisting diabetes 
affect placenta growth kinetics and contribute to the fetus developing hyperinsulinemia.16 Fetal 
hyperinsulinemia increases the glucose gradient across the placenta and consequently the 
glucose flux to the fetus in an effort to decrease fetal glycemia. The gradient is greatest when 
maternal hyperglycemia and fetal hyperinsulinemia coexist, but fetal hyperinsulinemia favors the 
high gradient even when maternal blood glucose is normal.16 To prevent the development of 
fetal hyperinsulinemia, maternal glycemic control needs to be established early in pregnancy.16  
Hyperglycemia in early pregnancy coupled with taking potentially teratogenic diabetes 
medication leads to adverse fetal outcomes.19 Maternal fasting blood glucose measured at nine 
to ten weeks gestation is directly correlated with risk for a large for gestational age birth.16 
Around 14 weeks gestation, maternal hyperglycemia induces fetal hyperinsulinemia, 
accelerated growth, and excess adiposity which may result in macrosomia.20  Macrosomia 
occurs due to increased transport of maternal glucose and amino acids to the fetus which 
results in excessive fetal insulin. Excessive insulin and maternal substrates promote excessive 
fetal growth. Obese and overweight mothers have a two-fold increased risk of delivering a 
macrosomic infant.21 An observational retrospective study by Cyagnek, et. al., indicated that 
there is a linear relationship between third trimester hemoglobin A1c (HbA1c) and macrosomia 
risk in HbA1c range from 4.5 to 7.0%.22 Macrosomia occurs in 27 to 62% of infants of diabetic 
mothers and is associated with increased rate of operative delivery, birth trauma, fetal loss, and 
neonatal hypoglycemia.20 Macrosomic infants of diabetic mothers also have increased hospital 
admissions during the neonatal period for hypoglycemia, jaundice, respiratory distress and 
asphyxia.23 Macrosomia is also associated with increased incidence of shoulder dystocia, 
brachial plexus injury, and malpresentation.24 Macrosomic infants are at an increased risk of for 
long-term complications such as obesity and insulin resistance.25 Glycemic control is necessary 
through the entire pregnancy to prevent diabetic fetopathy (e.g., macrosomia).16 
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Pregestational Diabetes and Pregnancy Outcomes 
Poorly managed diabetes mellitus during pregnancy is associated with poor fetal health 
outcomes.26 Lack of glycemic control during fetal organogenesis which occurs during the first 
few weeks of pregnancy is correlated with spontaneous abortion and congenital 
malformations.20 A study by Zhao, et. al., revealed that hyperglycemia during pregnancy 
induces the development of hyperglycemia in the embryo before the onset of insulin production 
which affects the expression of genes involved in cell proliferation, cytoskeleton, and energy 
metabolism.27 Maternal diabetes is highly associated with congenital malformations of the 
cardiovascular and neural systems due to some genes being differentially regulated by 
hyperglycemia.27 Congenital malformations that are often reported include neural-tube and heart 
defects, kidney dysgenesis and the caudal regression syndrome.27 Neurodevelopmental 
outcomes effected by preexisting diabetes during pregnancy include lower long-term cognitive 
function and poor academic performance, higher risk of autism and attention deficit/hyperactivity 
disorder.18 Diabetes in pregnancy also increases the risk of the infant developing obesity or type 
2 diabetes later in life.28 The long-term developmental programming in the infant caused by 
diabetes during pregnancy may also lead to adverse cardiometabolic profiles and greater risk of 
hospital admissions, medication, and mortality.18,29 Uncontrolled diabetes during pregnancy 
increases the risk of the infant developing infections as a result of cesarean delivery.29 
Preexisting diabetes during pregnancy is also associated with the premature rupture of 
membranes (PROMs) in which the amniotic membrane ruptures before 37 weeks gestation. 
Complications of PROMs include intra-amniotic infection, placental disruption, fetal distress, 
fetal restrictive deformities, pulmonary hypoplasia, preterm birth, and fetal or newborn loss.30  
Maternal complications related to lack of glycemic control during pregnancy include 
progression of retinopathy and nephropathy, preeclampsia, and preterm labor.20 Type 2 
diabetes during pregnancy is associated with higher risk of perinatal mortality and type 1 
diabetes is associated with higher rates of diabetic ketoacidosis and cesarean delivery.18 
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Obesity is common among women with preexisting diabetes. One third of pregnant women are 
reported to be overweight or obese, which increases with age.24 Obesity during pregnancy is 
associated with greater congenital malformations, especially cardiac defects.18 Research 
indicates that the coexistence of obesity and diabetes increases the likelihood of adverse 
maternal and fetal outcomes.24 High prepregnancy BMI levels are correlated with preterm births 
and large for gestational age preterm infants.24 Obesity and macrosomic fetus rates increase 
cesarean delivery rates. Gestational weight gain increases the incidence of adverse pregnancy 
outcomes.24 Women that are obese are more likely to have hypertension, hyperlipidemia, and 
obstructive sleep apnea (OSA). OSA is linked to higher rates of gestational hypertension, 
preeclampsia, preterm birth, and greater need for neonatal intensive care units. OSA is also 
associated with worse glycemic profiles and insulin resistance. Pregnant women with chronic 
hypertension and diabetes have higher risk of pregnancy loss, preterm delivery, and low birth 
weight.18 Adverse postpartum outcomes are associated with elevated HbA1c levels before 
pregnancy and early pregnancy.29 Women with comorbidities, such as hypertension or obesity, 
would benefit from individualized care to reduce the risk of adverse pregnancy outcomes.18 
Women with preexisting diabetes are at an increased risk of developing preeclampsia, 
gestational hypertension, and polyhydramnios.24 Risk factors for preeclampsia among women 
with preexisting diabetes include nulliparity, advanced maternal age, previous preeclampsia, 
hypertension, a longer duration of diabetes, microalbuminuria, nephropathy and retinopathy, 
and poor glycemic control.31 Most pregnant women with preexisting diabetes require an 
increase in insulin dosage with advanced gestation, but a proportion of women require a 
reduction in insulin requirements during late pregnancy. This decrease in insulin requirements is 
associated with preeclampsia, small for gestational age, and increased admission to the 
neonatal intensive care unit. Falling insulin requirements are considered to be a marker of fetal 
placental compromise, prompting hospital admission and potential risk of early delivery. An 
imbalance of placental biomarkers such as proangiogenic factors, placental growth factor 
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(PlGF), and antiangiogenic factors, such as soluble fms-like tyrosine kinase 1 (sFlt-1) are used 
to predict and diagnose obstetric complications associated with placental dysfunction. In women 
with falling insulin requirements, the sFlt-1/PlGF ratio was higher regardless of factors that have 
previously been shown to lower PlGF levels, including maternal age, BMI, ethnicity, nulliparity, 
and smoking status indicating placental dysfunction. Women with preeclampsia had even higher 
sFlt-1/PlGF ratio at 25 and 36 weeks.32  
Pregestational Diabetes and Prepregnancy Care 
Although rates of unintended pregnancies have decreased in past years, nearly half of 
all pregnancies in the US are unplanned.18 Many women do not seek preconception care and 
planning for diabetes due to certain maternal characteristics including poor health literacy, 
tobacco use, being unmarried, lower family income, and poor relationships with providers.18 
Studies indicate that glycemic control early in pregnancy is integral due to fetal organogenesis.18 
Research also indicates that the maternal metabolic environment affects fetal growth as early as 
prepregnancy, through modification of oocyte metabolism.16 Women that do not participate in 
prepregnancy planning place their offspring at greater risk for developing congenital anomalies 
associated with uncontrolled diabetes.18 Elevations of HbA1c in early pregnancy are directly 
proportional to increased risk of diabetes embryopathy including anencephaly, microcephaly, 
congenital heart disease, renal anomalies, and caudal regression.14 Prepregnancy care is 
associated with improved glycemic control early in pregnancy and subsequent decreased risk of 
adverse outcomes. Prepregnancy care results in reduced risk of spontaneous abortion, adverse 
pregnancy outcomes, and premature delivery (before 34 weeks’ gestation).21 A lack of 
prepregnancy care is associated with higher rates of macrosomia and congenital malformations 
among women with pregestational diabetes.15 Common challenges of diabetes management 
include lack of knowledge among women and health care providers and limited access to 
prepregnancy diabetes care.15  
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Women with diabetes should be educated at the onset of diabetes or during puberty 
about the risks of unplanned pregnancy and diabetes.18 Prepregnancy care results in improved 
HbA1cs, reduced glycemic variability, and decreased hypoglycemic events and improved 
awareness.33 Glycemic assessment at the end of the first trimester does not adequately 
represent glycemic control at the time of organogenesis, emphasizing the importance of early 
assessment amongst women with preexisting diabetes.21 In a recent study that explored 
women’s experiences and perceptions of pregnancy-related diabetes management and support 
systems facilitating their self-management, most women reported lack of support and 
empathetic engagement from their health care team.34 Education and support that is provided 
by a registered dietitian nutritionist (RDN) or certified diabetes educator (CDE) during perinatal 
care may initiate positive behavior change and optimize glycemic control, which can have 
improved outcomes of pregnancy, childbirth, and early parenting.  
Management of Pregestational Diabetes  
Pregnant women with preexisting diabetes that face greater social deprivation are less 
likely to achieve glycemic control.19 Social determinants of health may dictate the level of 
lifestyle change women adhere to, further complicating the type of education that is needed.35 
Social determinants of health are the conditions in the environment in which people exist that 
affect their health, functioning, and quality of life. These may include quality of education, 
employment status, access to health services, cultural demands, and social support which all 
influence the management of diabetes during pregnancy.36 Evidence indicates that epigenetic 
processes are main contributors by which environmental stimuli activate disease promoting 
pathways.37 Racial and ethnic disparities exist among women with pregestational diabetes. 
Higher rates of pregestational diabetes occur among Black, Hispanic, and Alaska 
Native/American Indian women and lower rates in non-Hispanic, White, and Asian women.38 
The outcomes of current diabetes and nutrition education interventions need to be examined to 
promote improved quality of care and birth outcomes for all pregnant women with preexisting 
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diabetes. Diabetes education provided by RDNs or CDEs is the foundation to help women with 
diabetes navigate the multitude of daily self-management decisions and perform complex care 
activities. Studies have shown that care provided by a multidisciplinary team from preconception 
through pregnancy is associated with improved diabetes and pregnancy outcomes.14 For 
women with preexisting diabetes, preconception care is an opportunity to review diabetes 
management, adjust medications, and manage comorbidities.39 The assessment of 
prepregnancy care by Newman, et. al., included optimizing glycemic control, folic acid use, and 
smoking cessation to improve pregnancy outcomes among women with pregestational 
diabetes.40 The goals of the American Diabetes Association (ADA) are to improve the patient 
experience of care and education, to improve the health of individuals and populations, and to 
reduce diabetes-associated per capita health care costs.2  It is the responsibility of the health 
care community to provide quality care that mobilizes efforts to address barriers and explore 
resources for diabetes and nutrition education in order to meet the needs of pregnant women 
with preexisting diabetes.2  
A full spectrum of modifiable risk factors are associated with preexisting diabetes 
including optimization of blood glucose levels and supported lifestyle changes.40,41 Glycemic 
targets are stricter during pregnancy and women need to be assisted in establishing food plans 
with an ideal insulin to carbohydrate ratio to avoid hyperglycemia or hypoglycemia.14 Nutrition 
education focuses on key factors that are common among healthful eating patterns including 
emphasizing non-starchy vegetables, minimizing added sugars and refined grains, and 
choosing whole foods over highly processed foods to the extent possible.6 The American 
College of Obstetrics and Gynecology recommends self-monitoring of blood glucose using 
fingerstick glucose values recorded in glucose logs. Glucose logs are commonly reviewed at 
least every one to two weeks during the first two trimesters and weekly after 24 to 28 weeks of 
gestation in order to adapt the treatment regimen to fluctuating insulin needs.38 Fasting, pre-
prandial, and postprandial monitoring of blood glucose is recommended to achieve glycemic 
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control. The ADA recommendations for blood glucose levels are listed in the Operational Terms 
section of this paper. Individualized treatment goals may need to be established if women are 
not able to safely reach recommended targets. Frequent titration of insulin is common during 
pregnancy because of the changes in insulin resistance, underscoring the importance of 
frequent self-monitoring. Research is limited regarding the efficacy of using metformin and 
glyburide, making insulin therapy the optimal choice.14 RDNs and CDEs play a vital role in 
helping women manage glycemic control.4 Glycemic control is variable during pregnancy and 
research is limited regarding optimal targets for fasting and postprandial glycemia.14 ADA 
defined targets should be individualized for women at risk of hypoglycemia.14 Women with type 
1 diabetes are more likely to experience hypoglycemia due to an altered counterregulatory 
response which decrease hypoglycemia awareness during pregnancy.14 Women are also at risk 
for ketoacidosis due to the ketogenic state of pregnancy from increased maternal metabolic 
needs and fetal demands.14 Education provided by RDNs and CDE includes a specific 
carbohydrate to insulin ratio to prevent hypoglycemia and hyperglycemia during pregnancy.14  
Women may need regular counseling sessions to not only help manage the changes in 
insulin resistance but also to establish and maintain weight management goals during 
pregnancy.14 Recommended weight gain during pregnancy for overweight women is  
15 to 25 pounds and for obese women is 10 to 20 pounds. The ADA states that there is no 
optimal weight gain versus weight maintenance in women with a BMI > 35 kg/m2.14 Developing 
healthy eating patterns perinatally help decrease diabetes comorbidity risks. 
The American Heart Association recognizes preeclampsia as a risk factor for future 
cardiovascular disease and stroke in women.42 Maternal risk factors for preeclampsia include 
prepregnancy obesity, advanced maternal age, black race, and chronic hypertension.42 Women 
that are preeclamptic during pregnancy and have preexisting diabetes are at higher risk of 
microvascular complications later in life.42 Pathophysiology of preeclampsia is elusive but it has 
been hypothesized that women who develop preeclampsia are more insulin resistant prior to 
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pregnancy.42 There are different stages of high blood pressure during pregnancy: gestational 
hypertension, mild preeclampsia, severe preeclampsia, and eclampsia (see Operational 
Definitions). Medical nutrition therapy (MNT) and diabetes self-management education (DSME) 
improve glycemic control and hypertension through individualized lifestyle interventions. 
Diabetes nutrition education includes developing an eating plan designed to optimize blood 
glucose trends, blood pressure, and lipid profiles which decreases markers of cardiovascular 
disease and hypertension.6 Diet modifications may include a DASH-style diet (Dietary 
Approached to Stop Hypertension), increasing fiber, and decreasing saturated fat and 
cholesterol.6 Poor glycemic control and insulin resistance are risk factors for preeclampsia. 
Research is limited regarding the role that MNT plays in the prevalence of preeclampsia during 
pregnancy. Diabetes counseling provided by a RDN or CDE should include an explanation of 
the maternal and fetal risks associated with pregnancy and ways to reduce risk. 
Providers need to be empathetic and supportive with their approaches.14 Numerous 
reports have identified the negative psychological impact on pregnant women with preexisting 
diabetes due to the demanding glucose management regimen from preconception to birth.34 
Women with preexisting diabetes during pregnancy experience greater levels of stress, anxiety, 
and worry related to the difficulty of comanaging diabetes and pregnancy.34 Through a 
retrospective quality improvement study, existing data that reflects current practices and 
operational approaches to diabetes and nutrition education can be extracted and disseminated 
to foster quality improvement initiatives and explore the efficacy of RDNs and CDEs.13 
Quality Improvement of Pregestational Diabetes Education 
This retrospective chart review focused on diabetes education and nutrition education 
provided by an urban Alaska health system and the subsequent birth outcomes of women with 
preexisting diabetes related to perinatal glycemia, pregnancy risks, and potential confounding 
factors to drive quality improvement. Annually in the United States, approximately 0.9% of the 4 
million births are complicated by preexisting diabetes.18 The Pregnancy Risk Assessment 
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Monitoring System 2009 to 2010 found that only 53% of women with preexisting diabetes 
received preconception care before pregnancy.39 Although the rate of diabetes among women 
of childbearing age in Alaska is lower than the national average (7.6% versus 8.3%), it is 
steadily rising every year, increasing the cost of healthcare as well as the burden on the 
family.43 The Indian Health Services Diabetes Care and Outcomes Audit indicated that in 2014, 
54% of female Alaska Native people statewide seen at any IHS facility had diabetes.44 The 
Centers for Disease Control and Prevention reported that from 2000 to 2010 the percentage of 
preexisting type 1 and type 2 diabetes amongst women aged 18 to 44 has increased 37% in the 
U.S.45 It is indisputable that there is a need for focused perinatal diabetes and nutrition 
education. All women with pregestational diabetes need to receive individualized education to 
develop appropriate diabetes self-management skills and knowledge during pregnancy, which 
promotes positive birth outcomes and ultimately improves the health of our next generation. By 
completing a retrospective chart review with a focus on outcomes research for the purposes of 
quality improvement, the effectiveness of diabetes or nutrition education during pregnancy can 














Chapter 3: Methods 
After receiving University of Alaska Anchorage and Swedish Institutional Review Board 
approval (Appendix A), a retrospective chart review focused on outcomes research was 
conducted at an urban Alaska health system for the purposes of quality improvement. Inclusion 
criteria included: females of childbearing age, type 1 or type 2 diabetes diagnosis prior to 
pregnancy, and patient at an urban Alaska health system. Exclusion criteria included gestational 
diabetes diagnosis and nonpregnant women. Eighty-five medical records of previously pregnant 
women were reviewed. Medical charts were reviewed for all women that had pregestational 
diabetes from 2017 to 2019 and gave birth at an urban Alaska health system. The urban Alaska 
health system includes an inpatient hospital, neuroscience center, outpatient diabetes and 
nutrition center, urgent care facilities, extended care facility, family medical center, behavioral 
health facility, maternal-fetal medicine clinic, palliative care clinic, laboratory services, pediatric 
clinics, palliative care clinic, rehabilitation center, and a pulmonology and sleep clinic. Data 
collected included completion of diabetes education, completion of nutrition education, 
demographics (age, ethnicity, gravida para, employment status), type of diabetes, duration of 
diabetes diagnosis, BMI, patient health history (chronic hypertension), blood sugar levels for 
each trimester, HbA1c for each trimester, birth outcomes (gestational age, birth weight, mode of 
delivery, shoulder dystocia, malpresentation, premature rupture of membrane, postpartum 
hemorrhage, fetal loss), and pregnancy complications (preeclampsia) (Appendix B). Completion 
of diabetes or nutrition education was identified as yes or no based on documentation in the 
education portion of the medical record. Health system staff extracted data and provided it to 
the principal investigator. All personal health information was de-identified and coded at the 
point of extraction and kept on a password protected computer. Data was stored on password 
protected computer until the conclusion of the research project, at which point it will be 
destroyed. Outcome measures included HbA1c during each trimester (if available) and resultant 
birth outcomes.  
15 
 
For this project it was assumed that measures of HbA1c during the first trimester 
indicate prepregnancy glycemia which is a surrogate marker for diabetes control prior to 
conception related to the completion of preconception education. Diabetes and nutrition 
education were assumed to be provided by a RDN or CDE. Data regarding which trimester 
diabetes education and nutrition education was completed was not included in this research 
project. It is also unknown whether all women received referrals for diabetes education or 
nutrition education. No assumptions were made regarding blood sugar levels due to the 
variability of acceptable fasting levels compared to postprandial levels. 
Analysis 
Demographic assessment 
All statistical analyses were performed using SPSS software, version 26.46 Some 
variables were excluded due to lack of availability in medical charts. Excluded variables 
included preconception care, blood glucose values, number of missed appointments, 
medication, educational attainment, and income. Of the 85 charts reviewed, 78 charts were 
included in the analysis. Five charts were excluded due to women having gestational diabetes 
and not preexisting diabetes, one chart was for an infant, and one was excluded for 
confidentiality reasons. Once data was compiled into a table (Appendix B), descriptive statistics 
were computed for continuous and categorical variables. Continuous variables included age, 
BMI, duration of diabetes, preconception HbA1c, HbA1c during each trimester, blood glucose 
during each trimester, and gravida para. Categorical data included health history (chronic 
hypertension), diabetes type, employment status, ethnicity, birth outcomes (birth weight, 
gestational age, cesarean delivery, shoulder dystocia, malpresentation, premature rupture of 
membrane, postpartum hemorrhaging, and fetal loss), pregnancy complications (preeclampsia), 
diabetes education, nutrition education. Continuous variables including age-related pregnancy 
risk, BMI-related pregnancy risk, and multiparity were also categorized as categorical variables 
in order to run chi-square contingency tables. 
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Relationships between variables 
To examine relationships for all objectives in this project, Chi square test for association 
was completed for multiple variables. Chi square compared the association between education 
(diabetes or nutrition) and outcomes measures (birth outcomes and HbA1c preconception and 
during each trimester). This analysis compared observed frequencies of education (diabetes or 
nutrition) with what was expected if there was no association between variables being 
measured. Data was coded in preparation for Chi square. Acceptable blood glucose was 
defined using the American Diabetes Association Management of Diabetes in 
Pregnancy: Standards of Medical Care in Diabetes – 2020 recommendation of HbA1c < 6.5%, 
which accounts for preconception and perinatal targets.14 Women were divided into two 
categories (yes/no) depending on if they had any of the following birth outcomes: shoulder 
dystocia, premature rupture of membrane, postpartum hemorrhage, malpresentation, or fetal 
loss. Other outcomes include preterm birth (yes/no), cesarean section (yes/no) completion of 
diabetes education (yes/no), completion of nutrition education (yes/no), and macrosomic infants 
(yes/no). Pregnancy complications, such as high blood pressure during pregnancy was 
categorized as yes/no in preparation for Chi square. High blood pressure during pregnancy 
included gestational hypertension, mild preeclampsia, and eclampsia and severe preeclampsia. 
Age was coded as yes/no for age-related pregnancy risk (greater than 35 years old). Similarly, 
prepregnancy BMIs were categorized as yes/no for BMI-related pregnancy risk (greater than 
23.9 kg/m2). Chronic hypertension and multiparity were also coded as a pregnancy risks as 








Chapter 4: Results 
Sample Demographics  
The mean age of the sample was 31 years old (S.D. + 5.5) and the mean BMI of the 
sample was 31 kg/m2 (S.D. + 8.6) (Table 1). More women had type 2 diabetes (64.1%, n = 50) 
than type 1 diabetes (35.9%, n = 28) and the mean duration of diabetes diagnosis was 10 years 
(S.D. + 9.0) (Table 2). The HbA1c levels during preconception were 8.2% (S.D. + 1.9), first 
trimester was 7.8% (S.D. + 1.6), second trimester was 7.5% (S.D. + 1.9), and HbA1c in the third 
trimester was 7.0% (S.D. + 1.1). Blood glucose levels were also collected for each trimester, 
during the first trimester the mean blood glucose level was 200 mg/dL (S.D. + 86.7), second 
trimester 132 mg/dL (S.D. + 64.4), and third trimester 140 mg/dL (S.D. + 74.0). Descriptive 
statistics also indicated that 30.8% (n = 24) of women had chronic hypertension. The mean 
number of previous pregnancies within the sample was 3 (S.D. + 2.0) and the mean number of 
previous births was 1.0 (S.D. + 2.0). Pregnancy complications included eclampsia and severe 
preeclampsia (12.8%, n = 10), mild preeclampsia (6.4%, n = 4), and gestational hypertension 
(5.1%, n = 4). In terms of birth outcomes, more women had a cesarean delivery (60.3%, n = 47) 
than a vaginal delivery (39.7%, n = 31). Most women gave birth during weeks 37 to 38 (43.6%, 
n = 34) and weeks 34 to 36 (38.5%, n = 30). Sample preterm births included 5.1% (n = 4) during 
weeks 28 to 33, 3.8% (n = 3) during weeks 24 to 27, and 1.3% (n = 1) at less than 24 weeks. 
Within the sample 26.9% (n = 21) of the infants were born macrosomic (weighing greater than 
4000 grams at birth). The remaining sample gave birth to infants weighing 3500 to 3999 grams 
(25.6%, n = 20), 3000 to 3499 grams (24.4%, n = 19), 2500 to 2999 grams (10.3%, n = 8), 2000 
to 2499 grams (2.6%, n = 2), 1500 to 1999 grams (2.6%, n = 2), and less than 1500 grams 
(3.8%, n = 3). Additional birth outcomes included premature rupture of membranes (10.3%, n = 
8), shoulder dystocia (6.4%, n = 5), malpresentation (3.8%, n = 3), fetal loss (3.8%, n = 3), and 
postpartum hemorrhaging (2.6%, n = 2). Nutrition education was provided to 73.1% (n = 57) and 
diabetes education was provided to 74.4% (n = 58) of the sample.  
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Possible confounding factors related to not completing nutrition and diabetes education 
and subsequent glycemic and birth outcomes were also analyzed. Within the sample, 55.4%  
(n = 41) were employed. Results indicated that 50% (n = 37) of the sample were White, 23% (n 
= 17) were Native Hawaiian/Pacific Islander, 13.5% (n = 10) were Asian, 6.8% (n = 5) were 
Black, and 6.8% (n = 5) were Hispanic (Table 1 and Table 2).  Educational attainment and 
income information were not available in the medical charts
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Table 1. Sample Demographics – Continuous Data  
Continuous data Mean + 
standard 
deviation 
n Minimum Maximum 
Age (y) 
 




34.9 + 8.8 74 22 59 
Duration of DM 
 

































140 + 74.0 52 71 408 
Gravida 
 
3.0 + 2.0 73 1 12 
Para 
 







Table 2. Sample Demographics – Categorical Data 























































































Table 2. Continued.  
Categorical Data n (%) 





























































 To compare data to previous research, a medical chart review by Newman, et. al., was 
evaluated. Newman et. al., retrospectively analyzed data from 2015 to 2017 and compared 
outcomes to data from 2010 to 2014 to assess if improvements related to preconception care 
were maintained in subsequent years. The study included women with pregestational diabetes 
and examined glycemic targets and neonatal outcomes. This study included similar variables to 
the current study including age, BMI, HbA1c during each trimester, macrosomia, preterm births, 
and shoulder dystocia. Demographic characteristics from each study were compared to one 

















Table 3. Demographic Comparison 
 Urban Alaska 
chart review 
(n = 78) 
Newman, et. al., 
2010-2014 
(n = 228) 
Newman, et. al., 
2015-2017 
(n = 98) 
Age (y) 
 
31.3 + 5.5 33 + 5.1 33.6 + 5.1 
Body mass index 
(kg/m2) 
 




58 (74.4%) DE a 
57 (73.1%) NE b 




7.8 + 1.6  
(n = 38) 
7.3 + 2.5c 
6.7 + 2.6  
7.0 + 3.1  




7.5 + 1.9 
(n = 27)  
6.4 + 2.3 
6.0 + 2.3 
6.4 + 3.0  




7.0 + 1.1 
(n = 24) 
6.4 + 2.3 
6.0 + 2.3 
6.4 + 2.9 
5.5 + 3.0 























a DE: Diabetes education 
b NE: Nutrition education 










Relationships Between Variables 
For one analysis the Chi square assumptions were not met. Due to missing information 
in the medical charts, the unmet assumption violated the ‘minimum expected cell frequency’, 
which should be five or greater. The remaining Chi square tests that met the assumptions are 
depicted in Table 4. The only significant association found is between acceptable HbA1cs in the 
second trimester and White women (p = 0.013). Significance was determined as a p value of 





















Table 4. Chi Square Results 




Birth outcomesa 0.136 0.712 








Birth outcomes 0.002 0.965 












a Birth outcomes in this analysis include: shoulder dystocia, PROMs, postpartum hemorrhage, 
malpresentation, and fetal loss 
b Unacceptable HbA1c is > 6.5% 
c Significant value is < 0.05 














Chapter 5: Discussion 
Diabetes during pregnancy is associated with increased risk of maternal and neonatal 
complications and constitutes a significant medical, social, and financial issue.22 By examining 
current practices in relation to the American Diabetes Association Management of Diabetes in 
Pregnancy: Standards of Medical Care in Diabetes – 2020 and subsequent pregnancy 
outcomes, institutions can drive quality improvement for future practices in healthcare.13 
Improving current practices related to management of pregestational diabetes in pregnancy will 
help combat diabetic fetopathy and the intergenerational cycle of diabetes that increases health 
care costs and familial hardship.12  
Evaluation of Glycemic Control Outcomes  
The evaluation of outcome measures is an integral part of establishing the efficacy of 
RDNs and CDEs. These measures reflect the effect that current diabetes and nutrition 
education have on glycemic control during pregnancy. In addition to outcome measures being 
documented, it is necessary to record the measures of glycemic control that most accurately 
reflect fluctuating perinatal glycemia. The present study utilized HbA1c as a biomarker for 
glycemic control. Research has reported that individualized RDN-administered MNT accounts 
for statistically significant HbA1c reductions of 0.9% to 1.9% and the added benefit of DSME 
results in HbA1c reductions exceeding 2.0%.4 Marincic, et. al., indicated that patients with 
HbA1c > 7% have been reported to exhibit total health care costs that are 32% higher than 
those with sustained HbA1c in the target range.4 Despite acceptable HbA1c levels during 
pregnancy, the risk of macrosomia remains high in women with type 1 diabetes. This may 
suggest inadequacy of HbA1c as a solitary outcome measure because it misses significant 
episodes of hyperglycemia.22 The ADA suggests that HbA1c represents a consolidated 
measure of glucose, reporting a broad view of what blood sugars have been over a period of 
two to three months. This measure does not capture postprandial hyperglycemia which drives 
macrosomia.14 Furthermore, research has suggested that there is a physiological fall in HbA1c 
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in pregnancy, which may be due to increasing erythrocyte production rate, reduced glucose 
affinity, and a shortened erythrocyte life span.8 This retrospective quality improvement chart 
review at an urban Alaska health system found limited retrospective data regarding perinatal 
glycemia for women entering the health system at the time of birth. It is impossible to correlate 
birth outcomes with perinatal glycemia if outcome measures are unavailable. Efficacy of RDNs 
and CDEs depends on adequate documentation of interventions and resultant clinical 
measures.  
In comparison to HbA1c, pre- and postprandial blood glucose monitoring provide 
immediate feedback of glucose excursions which guide insulin adjustments. Fasting and pre-
prandial glucose values may be more relevant to adverse pregnancy outcomes.17 In this 
retrospective quality improvement study, glucose values available in medical charts were not 
specified as fasting, preprandial, or postprandial. It was not possible to relate glycemic 
excursions with birth outcomes when the most prevalent variable defining “acceptable” blood 
glucose was HbA1c. Future research should focus on evaluating a continuum of blood glucose 
levels to help understand the relationship between perinatal glycemic control and birth 
outcomes among women with preexisting diabetes during pregnancy. A continuum of blood 
glucose levels, as would be available through continuous glucose monitoring (CGM) 
technologies, also aids in identifying periods during pregnancy where education and support 
provided by a RDN and/or CDE may be most useful. The ADA states that using a CGM-
reported mean glucose is superior to the use of estimated HbA1c given the changes in HbA1c 
that occur in pregnancy.2 
Sample Demographics 
The results of this study align with current research indicating changing demographics of 
the obstetric population. The mean age of mothers in the United States at first birth is 26.9 
years.47 National Vital Statistics data shows that of the 0.9% of pregnant women with preexisting 
diabetes, a higher percentage of women were greater than 40 years old compared to the urban 
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Alaska health system review mean age of 31.3 + 5.5 years and Newman, et. al.’s mean age of 
33 + 5.1 years.48 
Obesity is often associated with type 2 diabetes and is becoming more prevalent in  
type 1 diabetes.6,14 Excessive weight gain during pregnancy is associated with increased risk of 
adverse pregnancy outcomes in subsequent pregnancies.14 The majority of patients in the 
urban Alaska health system sample and Newman, et. al., sample were obese, according to 
mean BMI ranges 27.09 kg/m2 to 34.9 kg/m2. If appropriate, prepregnancy care should include 
risk assessment of obesity and lifestyle interventions to prevent or treat obesity.14  
Diabetic embryopathy is associated with HbA1c elevations during the first ten weeks of 
pregnancy. The ADA recommends that women achieve a HbA1c < 6.5% before conception due 
to its association with the lowest risk of preeclampsia, macrosomia, and congenital anomalies.14 
The rates of macrosomia and shoulder dystocia were lower in the Newman, et. al., study than 
were observed in this study.  It is possible that the timing of preconception education and 
universal access to medical care in Ireland, the origin of the Newman, et. al., data, had a more 
positive effect on birth outcomes.  
Maternal and fetal risks are greater in women with preexisting diabetes due to the 
degree of hyperglycemia, chronic complications, and comorbidities. The urban Alaska health 
system and Newman, et. al., review had varying HbA1c levels, possibly related to timing of 
education completion. The HbA1c levels were the more elevated in the urban Alaska health 
system review compared to Newman et. al., review. Uncontrolled glycemia is associated with 
adverse birth outcomes. The urban Alaska health system had a higher percentage of preterm 
births compared to Newman, et. al. In the urban Alaska health system chart review, the 
relationship between preterm births and unacceptable HbA1c in the second trimester was 
statistically non-significant (p = .152). Women can be educated on ADA recommendations for 
glycemic control and receive subsequent individualized interventions provided by a RDN or 
CDE to decrease pregnancy risks. The urban Alaska health system review included several 
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other birth outcomes that may be affected by diabetes education or nutrition education and 
perinatal glycemia including malpresentation, premature rupture of membrane, postpartum 
hemorrhaging, and fetal loss. 
Chronic hypertension and comorbidities are more prevalent among women with type 2 
diabetes and pregnancy loss is more prevalent in the third trimester. Diabetes in pregnancy is 
associated with an increased risk of preeclampsia.42 In the urban Alaska health system chart 
review most women did not have preeclampsia but 30.8% (n = 24) had chronic hypertension. 
The relationship between chronic hypertension and unacceptable HbA1c during the second 
trimester were statistically nonsignificant (p = 0.098) in the urban Alaska health system chart 
review. Major risk factors for preeclampsia include prepregnancy obesity, advanced maternal 
age, black race, and chronic hypertension.42 Diabetes education or nutrition education provided 
by an RDN or CDE should focus on managing comorbidities such as blood pressure. 
Several variables (i.e., ethnicity, mode of delivery, and gravida para) included in the 
chart review were later determined to be incomplete or outside the scope of this research 
project. The urban Alaska chart review revealed that most women that visited the health system 
were White followed by Native Hawaiian or Pacific Islander, Asian, Black and Hispanic. Email 
correspondence with the urban Alaska health system staff revealed that most Alaska Native 
women typically attended a different hospital, but it was suggested that they could have been 
included in one of the aforementioned ethnicity groups.  Of note, pregestational diabetes is most 
prevalent among American Indian/Alaska Native women in the U.S.48 Delivery method was 
decided to be irrelevant due to the multitude of possible implications for cesarean delivery (i.e., 
prolonged labor, abnormal fetal positioning, cord prolapse).49 Although gravida para was 
included in this chart review and multiparous women have a greater need for close glucose 
control due to parity being correlated with increased insulin needs, this is outside of the scope of 
RDNs and CDEs. 
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Diabetes Education and Nutrition Education 
  In the urban Alaska health system chart review 74.4% (n = 58) of women received 
diabetes education and 73.1% (n = 57) received nutrition education. However, it is not clear 
whether the other patients received a referral for education or when during pregnancy education 
was completed. Preconception education occurred among 35% (n = 34) to 49% (n = 112) in the 
Newman, et. al review. Timing of education and preconception planning may influence glycemia 
during pregnancy. Women that live in greater social deprivation are less likely to have access to 
perinatal resources, which may have affected completion of education.19 
Many women included in the retrospective chart review were only admitted to the health 
system to give birth. It was unknown whether women received preconception or prenatal 
nutrition and diabetes education because their charts only included what was accomplished 
within the urban Alaska health system. Assumptions can be made about barriers to completing 
nutrition and diabetes education based on previous research exploring the experiences and 
perceptions of pregnant women with preexisting diabetes. Many women reported anxiety related 
to the prospect that they could be responsible for their babies being diagnosed with diabetes at 
birth or later in life. The feelings of anxiety, guilt, panic, stress, and selfishness associated with 
discussing the risks and management of diabetes could result in women not attending education 
appointments. Simultaneously managing pregnancy and diabetes takes an emotional toll on 
women; they need to be empowered with support, encouragement, and knowledge to 
successfully navigate pregnancy complicated by preexisting diabetes.34   
The relationships between the completion of nutrition education and birth outcomes (p = 
0.965) and diabetes education and birth outcomes (p = 0.712) were statistically non-significant. 
Birth outcomes included shoulder dystocia, malpresentation, PROMs, postpartum hemorrhage, 
and fetal loss. The most common birth outcomes associated with uncontrolled pregestational 
diabetes are congenital malformations and spontaneous abortion. These common birth 
outcomes are correlated with a lack of glycemic control during fetal organogenesis which occurs 
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during the first few weeks of pregnancy.20 Prepregnancy care would have the biggest impact on 
preventing congenital malformations and spontaneous abortion. It is unknown which trimester 
diabetes education or nutrition education was completed in the urban Alaska health system 
chart review. 
Data collected regarding educational attainment and ethnicity support the need for 
individualized care focusing on cultural backgrounds, food availability, personal preferences, 
health literacy and numeracy, and the socioeconomic setting in which people live.6 In the urban 
Alaska health system chart review, a non-White ethnicity was associated with unacceptable 
HbA1c in the second trimester (p = 0.013). Evaluating barriers to diabetes education or nutrition 
education may help promote initiatives focusing on increasing access and acceptability.  
Outcome measures are an essential part of tracking success of educational programs 
and supporting the efficacy of RDNs and CDEs. Women with pregestational diabetes are at 
increased risk of adverse pregnancy outcomes. Nutrition education and diabetes education 
needs to be individualized and appropriately documented to help promote healthy pregnancies 
and drive quality improvement. Outcome measures for this project could not be determined due 
to lack of comprehensive data available. Documentation of outcomes measures is needed to 
distinguish associations between ADA approved education and birth outcomes before quality 
improvement recommendations can be made.  
Strengths and Limitations 
 A strength of conducting this retrospective chart review is that the sample of pregnant 
women with preexisting diabetes was not affected. All data were collected after women had 
given birth and this review had no effect on their pregnancy or well-being. An additional strength 
of this retrospective quality improvement study was that best practices were used when 
compared to previous research. Reviews by Newman, et. al., and Marincic, et. al., used similar 
outcome measures to assess the success of diabetes and nutrition education during 
pregnancy.13,40  
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There were several limitations of this study. A main limitation of this project’s chart 
review was that the principal investigator depended on health system staff to extract data. 
Another limitation was that medical professionals provided varying levels data into the medical 
charts of their patients, making consistency of data collection difficult. Data (perinatal glycemia) 
was also limited because many women included in this review only visited the urban health 
system to give birth. This resulted in an inadequate amount of blood glucose datapoints. 
Medical charts seldomly included confounding factors to receiving care (i.e., income, 
educational attainment, ethnicity). Recording confounding factors are essential for identifying 
health disparities to help guide future interventions.39 Confounding factors are also important to 
identify because they alter data during analysis. Women with pregestational diabetes with 
greater social deprivation are less likely to achieve glycemic control due to a decreased ability to 
achieve and maintain lifestyle changes.19,35 In the chart review, it could not be deciphered 
whether education appointments were made and subsequently missed or whether all women 
received a diabetes or nutrition education referral. The number of diabetes or nutrition education 
appointments women completed was also unknown. During data extraction, it was not verified if 
education was provided by a RDN or CDE. It is important to note that information missing from 
medical charts does not necessarily mean information was not gathered during the assessment 
or intervention. Lastly, the effects of poor glycemic control early in pregnancy were lacking in 
this review because spontaneous abortions and fetal malformations were not included in data 
collection. 
Outcome measures included in this retrospective quality improvement chart review were 
limited. Blood glucose was not used in the analysis due to data lacking specificity of when 
measures were taken (i.e., fasting, pre-prandial, postprandial). The American Diabetes 
Association (ADA) and the American College of Obstetricians and Gynecologists (ACOG) 
indicate that HbA1c is useful but it should be used as a secondary measure of glycemic control 
in pregnancy, after self-monitoring blood glucose.14,38 The ADA also specifies that self-
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monitoring blood glucose targeting pre- and postprandial recommendations remains the 
superior methodology.14 HbA1c, although not ideal, provided a biomarker of glycemic control 
over a two to three month period which was helpful in assessing prepregnancy and perinatal 
glycemia.  
The most significant barrier of this project was unavailable data in medical charts, 
making it difficult to analyze relationships between variables. Without documentation of outcome 
measures, the impact of education is unknown and the role that RDNs and CDEs play in 
diabetes management during pregnancy is unsubstantiated. The objectives of this research 
project aimed to examine the relationship between the completion of ADA approved diabetes or 
nutrition education with perinatal glycemia and birth outcomes and that could not be completed.   
34 
Chapter 6: Conclusion and Recommendations 
Diabetes self-management education (DSME) provided by a RDN and/or CDE has been 
shown to improve clinical outcomes (i.e., weight, BMI, HbA1c, and blood lipids), behaviors (i.e., 
self-monitoring blood glucose), and quality of life.50 DSME includes individualized medical 
nutrition therapy (MNT) in conjunction with pharmacotherapy, increased physical activity to 
promote weight loss or insulin sensitivity, and ongoing support and counseling based on level of 
behavior change.50 Despite the beneficial outcomes, many women with diabetes do not plan 
their pregnancies and receive diabetes and nutrition education.21 The uncovered cost of MNT 
and DSME provided by RDNs and CDEs limits education programs and decreases access to 
ADA recommended Standards of Medical Care.14 The inconsistent documentation of outcome 
measures or medical record sharing amongst facilities limits the ability to examine completion of 
ADA recommended education with glycemic control and subsequent pregnancy outcomes. 
Affordable access is integral to remedy the intergenerational cycle of diabetes related to poorly 
managed perinatal glycemia. By assessing outcomes, more funding and staff should be 
appropriated to provide the necessary education and instill diabetes self-management efficacy. 
This will ultimately improve birth outcomes and decrease costs associated with diabetes 
management.2 Diabetes is a chronic disease and necessitates regular follow-up appointments, 
especially during pregnancy when insulin resistance is inconsistent.4  
Future quality improvement studies should closely investigate aspects of perinatal 
education and subsequent outcome measures. Specific recommendations for future research 
include collecting a continuum of clearly defined blood glucose levels throughout pregnancy and 
include the use of continuous glucose monitoring technology to better understand glycemia 
during pregnancy in women with pregestational diabetes and subsequent birth outcomes. 
Secondly, a repository of information is needed to further demonstrate the efficacy of the RDN 
and the CDE and the nutrition education and diabetes education they provide to pregnant 
women with pregestational diabetes. The effect of diabetes and nutrition education provided to 
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women with preexisting diabetes could be more accurately analyzed if outpatient clinic charts 
were included in the chart review or if medical records were consistently shared between 
facilities. To eliminate barriers associated with data extraction, future retrospective chart reviews 
should be performed solely by the principal investigator after receiving training on the electronic 
health record system, if possible. 
The data from this study was insufficient to complete the planned analysis due to the 
previously mentioned limitations. Quality improvement reviews of medical treatment, such as 
perinatal nutrition and diabetes education, are reliant on medical documentation. Marincic, et. 
al., states “documenting patient outcomes is a first step in establishing the efficacy of RDN 
interventions.”4, p. 450 Evaluating the efficacy of RDN and CDE services relies on accurate 
charting of baseline data and outcome measures. The documentation of outcome measures 
provides the basis for the reimbursement of DSME and MNT, directs policy initiatives, and 
improves access and affordability of perinatal care provided by a multidisciplinary team in which 
RDNs and CDEs play an essential role.4  
More research is needed to support the efficacy of RDNs and CDEs in providing 
diabetes self-management education and medical nutrition therapy to women with 
pregestational diabetes. Currently there is no consensus on the structure of prenatal 
multidisciplinary care teams for pregestational diabetes and there is minimal evidence pertaining 
to the impact various methods of healthcare delivery have on pregnancy outcomes. Appropriate 
outcome measures need to be documented following care provided by a RDN or CDE to help 







Dietetics and Nutrition Practice Implications 
 Registered dietitian nutritionists (RDNs) and certified diabetes educators (CDEs) 
continue to establish the expertise they bring as part of the interprofessional healthcare team. It 
is important to be proactive in the care provided to female patients preconceptionally and 
perinatally. RDNs and CDEs need to promote health literacy and prepare women to have 
successful perinatal outcomes. During pregnancy, optimal glycemia reduces the risk of obstetric 
and neonatal complications.34 Population specific programs should be created and promoted to 
improve access to prenatal care. Preconception programs should help women with preexisting 
diabetes feel empowered and positive about their pregnancy experience, while also providing 
information about any potential risks and support for managing those risks.34 Poorly managed 
diabetes during pregnancy carries considerable risk to the mother and infant as well as 
unnecessary burden on health care services and society.41    
The valuable role that RDNs and CDEs play in promoting glycemic control during 
pregnancy is best supported by outcome measures being documented and analyzed. The 
analysis of variables leading to positive birth outcomes promote the development of affordable 
and accessible perinatal programs, ultimately improving the health of the next generation and 
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Appendix B: Updated Data Collection Templates 
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Table B-3. Perinatal Blood Glucose and HbA1c 
Sample Preconception 1st trimester 2nd trimester 3rd trimester 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
11     
12     
13     
14     
15     
16     
17     
18     
19     
20     
21     
22     
23     
24     








Appendix C: Dissemination 
Results of this retrospective quality improvement study will be disseminated to the health 
system in urban Alaska to aid in future staffing projections. This project could influence current 
diabetes education and record keeping provided at urban clinics in Alaska by addressing best 
practices and areas of improvement. Research findings support the need for outcome 
measures, specifically a blood glucose continuum, when providing MNT and DSME to 
pregnancy women with preexisting diabetes. Appropriate outcomes measures reinforce the 
efficacy of RDNs and CDEs. The final product of this research study will be an abstract 
submitted to the Journal of the Academy of Nutrition and Dietetics and the creation of a poster 
to submit for presentation at the Academy of Nutrition and Dietetics Food and Nutrition 
Conference and Expo. 
 
 
